Global Medical Microfluidic Devices Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Microfluidic Devices Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Microfluidics devices are tiny chips that perform chemical analyses of extremely small volumes of fluids such as blood. Lab-on-a-chip devices, which often use microfluidics, are providing for earlier, more cost-effective disease detection and many other uses, from monitoring to treatment. The global microfluidics market is driven by the demand for low-volume sample analysis and high-throughput screening methodologies and has been fueled by the introduction of advanced technologies, such as lab-on-chip and the demand for in vitro diagnostics (IVDs).
Medical Microfluidic Devices report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Microfluidic Devices market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from In-vitro Diagnostics (IVD) and Pharmaceuticals and Medical Devices are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Medical Microfluidic Devices industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Medical Microfluidic Devices key manufacturers include Roche, Abbott, Fluidigm Corporation, Johnson & Johnson, Siemens Healthcare, Agilent and Bio-Rad Laboratories, etc. Roche, Abbott, Fluidigm Corporation are top 3 players and held % sales share in total in 2022.
Medical Microfluidic Devices can be divided into Polymer, Glass, Silicon and Other, etc. Polymer is the mainstream product in the market, accounting for % sales share globally in 2022.
Medical Microfluidic Devices is widely used in various fields, such as In-vitro Diagnostics (IVD), Pharmaceuticals and Medical Devices and Other,, etc. In-vitro Diagnostics (IVD) provides greatest supports to the Medical Microfluidic Devices industry development. In 2022, global % sales of Medical Microfluidic Devices went into In-vitro Diagnostics (IVD) filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Microfluidic Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories
Segment by Type
Polymer
Glass
Silicon
Other
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Medical Microfluidic Devices market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Microfluidic Devices, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Microfluidic Devices industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Medical Microfluidic Devices in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Microfluidic Devices introduction, etc. Medical Microfluidic Devices Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Microfluidic Devices market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Medical Microfluidic Devices report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Microfluidic Devices market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from In-vitro Diagnostics (IVD) and Pharmaceuticals and Medical Devices are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Medical Microfluidic Devices industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Medical Microfluidic Devices key manufacturers include Roche, Abbott, Fluidigm Corporation, Johnson & Johnson, Siemens Healthcare, Agilent and Bio-Rad Laboratories, etc. Roche, Abbott, Fluidigm Corporation are top 3 players and held % sales share in total in 2022.
Medical Microfluidic Devices can be divided into Polymer, Glass, Silicon and Other, etc. Polymer is the mainstream product in the market, accounting for % sales share globally in 2022.
Medical Microfluidic Devices is widely used in various fields, such as In-vitro Diagnostics (IVD), Pharmaceuticals and Medical Devices and Other,, etc. In-vitro Diagnostics (IVD) provides greatest supports to the Medical Microfluidic Devices industry development. In 2022, global % sales of Medical Microfluidic Devices went into In-vitro Diagnostics (IVD) filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Microfluidic Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories
Segment by Type
Polymer
Glass
Silicon
Other
Segment by Application
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Medical Microfluidic Devices market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Microfluidic Devices, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Microfluidic Devices industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Medical Microfluidic Devices in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Microfluidic Devices introduction, etc. Medical Microfluidic Devices Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Microfluidic Devices market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices